A predictive metabolic signature for the transition from gestational diabetes mellitus to type 2 diabetes

Diabetes

Volumn 65, Issue 9, 2016, Pages 2529-2539

  Allalou, Amina ^a   Nalla, Amarnadh ^a,b   Prentice, Kacey J ^a   Liu, Ying ^a   Zhang, Ming ^a   Dai, Feihan F ^a   Ning, Xian ^c   Osborne, Lucy R ^a   Cox, Brian J ^a   Gunderson, Erica P ^c   Wheeler, Michael B ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c DIVISION OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BIOLOGICAL MARKER; FATTY ACID; GLUCOSE; HEXOKINASE; KETONE BODY; GLUCOSE BLOOD LEVEL;

ADULT; AMINO ACID ANALYSIS; ARTICLE; BLOOD SAMPLING; BODY MASS; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DECISION TREE; DIABETIC PATIENT; DIAGNOSTIC VALUE; DIET RESTRICTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNICITY; FATTY ACID ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; LIQUID CHROMATOGRAPHY; MACHINE LEARNING; MAJOR CLINICAL STUDY; MASS FRAGMENTOGRAPHY; MEDICAL SOCIETY; METABOLITE; METABOLOMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREDICTIVE VALUE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUERPERIUM; RACE; SCREENING; TANDEM MASS SPECTROMETRY; BLOOD; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED; PREGNANCY; YOUNG ADULT;

ADULT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INCIDENCE; MIDDLE AGED; POSTPARTUM PERIOD; PREGNANCY; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84987657375     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db15-1720     Document Type: Article

References (43)

1. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002;25:1862-1868
2. Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 2007;30(Suppl. 2):S141-S146
3. American Diabetes Association. Standards of medical care in diabetes- 2014. Diabetes Care 2014;37(Suppl. 1):S14-S80
4. Shah BR, Lipscombe LL, Feig DS, Lowe JM. Missed opportunities for type 2 diabetes testing following gestational diabetes: a population-based cohort study. BJOG 2011;118:1484-1490
5. Blatt AJ, Nakamoto JM, Kaufman HW. Gaps in diabetes screening during pregnancy and postpartum. Obstet Gynecol 2011;117:61-68
6. Bennett WL, Ennen CS, Carrese JA, et al. Barriers to and facilitators of postpartum follow-up care in women with recent gestational diabetes mellitus: a qualitative study. J Womens Health (Larchmt) 2011;20:239-245
7. Russell MA, Phipps MG, Olson CL, Welch HG, Carpenter MW. Rates of postpartum glucose testing after gestational diabetes mellitus. Obstet Gynecol 2006;108:1456-1462
8. Jones EJ, Roche CC, Appel SJ. A review of the health beliefs and lifestyle behaviors of women with previous gestational diabetes. J Obstet Gynecol Neonatal Nurs 2009;38:516-526
9. Kim C, McEwen LN, Piette JD, Goewey J, Ferrara A, Walker EA. Risk perception for diabetes among women with histories of gestational diabetes mellitus. Diabetes Care 2007;30:2281-2286
10. Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ. Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 2000;16:164-171
11. Rosella LC, Manuel DG, Burchill C, Stukel TA; PHIAT-DM team. A populationbased risk algorithm for the development of diabetes: development and validation of the Diabetes Population Risk Tool (DPoRT). J Epidemiol Community Health 2011;65: 613-620
12. Deo RC. Machine Learning in Medicine. Circulation 2015;132:1920-1930
13. Yi L, Yuan D, Che Z, et al. Plasma fatty acid metabolic profile coupled with uncorrelated linear discriminant analysis to diagnose and biomarker screening of type 2 diabetes and type 2 diabetic coronary heart diseases. Metabolomics 2008; 4:30-38
14. Adams SH, Hoppel CL, Lok KH, et al. Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. J Nutr 2009;139: 1073-1081
15. Fiehn O, Garvey WT, Newman JW, Lok KH, Hoppel CL, Adams SH. Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. PLoS One 2010; 5:e15234
16. Mihalik SJ, Goodpaster BH, Kelley DE, et al. Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity (Silver Spring) 2010;18:1695-1700
17. Suhre K, Meisinger C, Döring A, et al. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One 2010; 5:e13953
18. Wang TJ, Larson MG, Vasan RS, et al. Metabolite profiles and the risk of developing diabetes. Nat Med 2011;17:448-453
19. Wang-Sattler R, Yu Z, Herder C, et al. Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol 2012;8:615
20. Ha CY, Kim JY, Paik JK, et al. The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes. Clin Endocrinol (Oxf) 2012;76:674-682
21. Floegel A, Stefan N, Yu Z, et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 2013;62:639-648
22. Prentice KJ, Luu L, Allister EM, et al. The furan fatty acid metabolite CMPF is elevated in diabetes and induces β cell dysfunction. Cell Metab 2014;19:653-666
23. Lappas M, Mundra PA, Wong G, et al. The prediction of type 2 diabetes in women with previous gestational diabetes mellitus using lipidomics. Diabetologia 2015;58:1436-1442
24. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768-73
25. Gunderson EP, Matias SL, Hurston SR, et al. Study of Women, Infant Feeding, and Type 2 Diabetes Mellitus After GDM Pregnancy (SWIFT), a prospective cohort study: methodology and design. BMC Public Health 2011;11:952-963
26. Gunderson EP, Hedderson MM, Chiang V, et al. Lactation intensity and postpartum maternal glucose tolerance and insulin resistance in women with recent GDM: the SWIFT cohort. Diabetes Care 2012;35:50-56
27. Gunderson EP, Kim C, Quesenberry CP Jr, et al. Lactation intensity and fasting plasma lipids, lipoproteins, non-esterified free fatty acids, leptin and adiponectin in postpartum women with recent gestational diabetes mellitus: the SWIFT cohort. Metabolism 2014;63:941-950
28. Gunderson EP, Hurston SR, Ning X, et al.; Study of Women, Infant Feeding and Type 2 Diabetes After GDM Pregnancy Investigators. Lactation and progression to type 2 diabetes mellitus after gestational diabetes mellitus: a prospective cohort study. Ann Intern Med 2015;163:889-898
29. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2000;23(Suppl. 1):S4-S19
30. Wang TJ, Ngo D, Psychogios N, et al. 2-Aminoadipic acid is a biomarker for diabetes risk. J Clin Invest 2013;123:4309-4317
31. Tan B, Liang Y, Yi L, et al. Identification of free fatty acids profiling of type 2 diabetes mellitus and exploring possible biomarkers by GC-MS coupled with chemometrics. Metabolomics 2010;6:219-228
32. Kim S, Kim J, Zhang BT. Ensembled support vector machines for human papillomavirus risk type prediction from protein secondary structures. Comput Biol Med 2009;39:187-193
33. Metzger BE, Cho NH, Roston SM, Radvany R. Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care 1993;16:1598-1605
34. Aroda VR, Christophi CA, Edelstein SL, et al.; Diabetes Prevention Program Research Group. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. J Clin Endocrinol Metab 2015;100:1646-1653
35. Newgard CB, An J, Bain JR, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009;9:311-326
36. Menni C, Fauman E, Erte I, et al. Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach. Diabetes 2013;62:4270-4276
37. Samuel VT. Fructose induced lipogenesis: from sugar to fat to insulin resistance. Trends Endocrinol Metab 2011;22:60-65
38. Maedler K, Spinas GA, Dyntar D, Moritz W, Kaiser N, Donath MY. Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. Diabetes 2001;50:69-76
39. Peter Slotte J. Molecular properties of various structurally defined sphingomyelins-correlation of structure with function. Prog Lipid Res 2013; 52:206-219
40. Anderson SG, Dunn WB, Banerjee M, et al. Evidence that multiple defects in lipid regulation occur before hyperglycemia during the prodrome of type-2 diabetes. PLoS One 2014;9:e103217
41. Wang Q, Imamura F, Ma W, et al. Circulating and dietary trans fatty acids and incident type 2 diabetes in older adults: the Cardiovascular Health Study. Diabetes Care 2015;38:1099-1107
42. Mai M, Tönjes A, Kovacs P, Stumvoll M, Fiedler GM, Leichtle AB. Serum levels of acylcarnitines are altered in prediabetic conditions. PLoS One 2013;8:e82459
43. Waljee AK, Higgins PD, Singal AG. A primer on predictive models. Clin Transl Gastroenterol 2014;5:e44